| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. | 22% | $7,099,185 | 2,839,674 | Anders Hove | 15 May 2025 | |||
| Shay Capital LLC | 6.3% | $2,057,944 | 810,214 | Shay Capital LLC | 15 May 2025 | |||
| Prosight Management, LP | 5.8% | $2,214,578 | 745,649 | Prosight Management, LP | 24 Nov 2025 | |||
| VANGUARD GROUP INC | 5.6% | $2,084,862 | 706,733 | The Vanguard Group | 31 Dec 2024 | |||
| CANTOR FITZGERALD & CO. | 5.2% | $1,693,934 | 669,539 | Cantor Fitzgerald Securities | 30 Jun 2025 | |||
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5.2% | +67% | $1,678,926 | +$667,576 | 663,607 | +66% | Highbridge Capital Management, LLC | 30 Jun 2025 |
| Deep Track Capital, LP | 4.1% | $1,545,768 | 523,989 | Deep Track Capital, LP | 31 Dec 2024 | |||
| Lundbeckfond Invest A/S | 1.6% | $599,210 | 203,122 | Lundbeckfond Invest A/S | 31 Dec 2024 |
As of 30 Sep 2025, 42 institutional investors reported holding 10,219,608 shares of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR). This represents 79% of the company’s total 12,856,017 outstanding shares.
The largest institutional shareholders of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR) together control 79% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 22% | 2,839,674 | 0% | 4% | $7,809,104 |
| CITADEL ADVISORS LLC | 7.9% | 1,016,613 | -6.7% | 0% | $2,795,686 |
| Shay Capital LLC | 7.1% | 917,934 | +17% | 0.46% | $2,524,319 |
| VANGUARD GROUP INC | 5.3% | 678,226 | -4% | 0% | $1,865,122 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5.1% | 650,218 | -2% | 0.09% | $1,788,100 |
| Vestal Point Capital, LP | 4.9% | 635,000 | 0% | 0.08% | $1,746,250 |
| BlackRock, Inc. | 4.4% | 564,836 | +0.01% | 0% | $1,553,301 |
| StepStone Group LP | 3.8% | 491,938 | 0% | 0.67% | $1,352,830 |
| CANTOR FITZGERALD, L. P. | 3.8% | 491,863 | -27% | 0.03% | $1,352,623 |
| NEA Management Company, LLC | 3.7% | 478,548 | 0% | 0.07% | $1,316,007 |
| Carlyle Group Inc. | 2.1% | 269,895 | 0% | 0.02% | $742,211 |
| Prosight Management, LP | 2.1% | 267,959 | +68% | 0.18% | $736,887 |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 175,750 | +43% | 0% | $483,313 |
| Rangeley Capital, LLC | 1.2% | 155,490 | +420% | 0.41% | $427,598 |
| TANG CAPITAL MANAGEMENT LLC | 0.91% | 116,395 | -31% | 0.01% | $320,086 |
| Aisling Capital Management LP | 0.69% | 88,607 | 0% | 0.05% | $243,669 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.66% | 84,895 | 0% | 0% | $233,475 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.47% | 60,454 | 0% | 0.04% | $166,249 |
| GSA CAPITAL PARTNERS LLP | 0.46% | 59,224 | +172% | 0.01% | $163,000 |
| Aldebaran Capital, LLC | 0.34% | 43,997 | -0.4% | 0.11% | $120,992 |
| TWO SIGMA ADVISERS, LP | 0.21% | 26,608 | -0.82% | 0% | $73,172 |
| TWO SIGMA INVESTMENTS, LP | 0.2% | 25,435 | -1.7% | 0% | $69,946 |
| NORTHERN TRUST CORP | 0.18% | 22,510 | 0% | 0% | $61,903 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.15% | 19,500 | -22% | 0% | $53,625 |
| MORGAN STANLEY | 0.13% | 17,214 | +3.1% | 0% | $47,338 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 10,219,608 | $28,104,553 | -$1,295,979 | $2.75 | 42 |
| 2025 Q2 | 10,778,865 | $25,758,405 | -$10,457,910 | $2.39 | 48 |
| 2025 Q1 | 11,945,383 | $50,147,392 | -$1,567,884 | $4.30 | 46 |
| 2024 Q4 | 11,839,301 | $99,219,345 | +$88,962,026 | $8.60 | 49 |
| 2024 Q3 | 3,200 | $5,440 | +$5,440 | $1.70 | 1 |